After the lockdown, ICMR plans to ask all states and UTs to send positive Covid-19 samples to study the genetic diversity of the virus, which it says will help India prepare better.
The experimental antiviral drug that was developed by US pharmaceutical company Gilead Sciences has shown that it leads to faster recovery in Covid-19 patients.
CSIR will launch trials to see if sepsis drug can stop Covid-19 from progressing in asymptomatic patients & if it can prevent it from redeveloping in recovered patients.
A round-up of the most important reports in major newspapers around the country – from TOI and HT, Express and The Hindu to The Telegraph, Mumbai Mirror and The Tribune, as well as top financial dailies.
In an exclusive interview to ThePrint, Union Health Minister Harsh Vardhan also said the government is aiming to test one lakh people per day by 31 May.
Finance ministry says the proposed revamp will focus on structural reforms, rate rationalisation & ease of living, & will be deliberated upon in the coming weeks.
The project is meant to be a ‘protective shield that will keep expanding’, the PM said. It is on the lines of the ‘Golden Dome’ announced by Trump, it is learnt.
Standing up to America is usually not a personal risk for a leader in India. Any suggestions of foreign pressure unites India behind who they see as leading them in that fight.
COMMENTS